Factsheet
As of 18 Apr 2025
BIZ
-
Consumer Products
/
Personal Products & Pharmaceuticals
CG Report :
-
SET ESG Ratings :
-
Business Type
BIZ is a distributor and solution provider for medical devices and softwares for treating cancer through radiotherapy. The Company also provides installation services as well as after sales maintenance service for its products.
300.37
1,946.38
2,295.47
303.67
7.56
3.24
3.80 /
3.00
8.68
2.22
Company Profile
92/45 Sathorn Thani Building 2, 16th Floor, North Sathorn Rd., Bangrak Bangkok 10500
0-2636-6828-9
0-2236-3167
ASSET PRO MANAGEMENT COMPANY LIMITED
12/05/2000
28 Jul 2016
2.90 @Par Value
0.50
Baht
0.50
Baht
Old -
: New - @
-
Shareholders
As of -
3,305 (as of 04 Mar 2024)
20.30% (as of 04 Mar 2024)
10.72% (as of 18 Apr 2025)
49.00% (as of 18 Apr 2025)
3,355 (as of 08 Mar 2023)
20.24% (as of 08 Mar 2023)
1.14% (as of 18 Apr 2025)
Board of Directors / Management
5 Yr Price Performance (Adjusted Price)
Change
Price Performance (Adjusted Price)
Statistics
Accumulated: Turnover Ratio, Value Trade/Day
Rate of Return
Dividend
Latest News
Auditor (Effective Until 31 Dec 2025)
Mr. SAMRAN TAENGCHAM (EY OFFICE LIMITED)Mr. PIYA CHAIPRUCKMALAKARN (EY OFFICE LIMITED)Miss NATTEERA PONGPINITPINYO (EY OFFICE LIMITED)MISS SIRIWAN SURATEPIN (EY OFFICE LIMITED)
Unqualified opinion
31 Dec
Financial Statements Submission Information
Financial Data
Statement of Financial Position Unit: M.Baht
Statement of Comprehensive Income Unit: M.Baht
Statement of Cash Flow Unit: M.Baht
Ratios Annualized : ROE,
ROA
Growth Rate (%)
Cash Cycle Annualized
Capital Movement (Last 3 Year)
Information only PP, PO, XR and XD
Trading Sign (Latest)
- Calculated from adjusted price
- Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
- The information is quarterly updated within 7 business days after the new financial statement is submitted
- Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.